Bio-Rad Laboratories, Inc.
(NYSE : BIO)

( )
BIO PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.01%107.580.6%$463.80m
TMOThermo Fisher Scientific Inc.
1.11%283.771.0%$450.58m
ABTAbbott Laboratories
-0.26%79.610.8%$313.34m
ISRGIntuitive Surgical, Inc.
1.33%518.032.4%$291.82m
BSXBoston Scientific Corporation
0.66%38.231.1%$286.68m
EWEdwards Lifesciences Corporation
0.53%227.291.2%$251.89m
SYKStryker Corporation
1.17%213.761.3%$238.49m
BDXBecton, Dickinson and Company
1.77%252.951.1%$237.90m
ALGNAlign Technology, Inc.
3.09%200.166.3%$232.01m
BAXBaxter International Inc.
0.46%88.011.7%$226.86m
PODDInsulet Corporation
-2.19%150.036.9%$158.16m
ZBHZimmer Biomet Holdings, Inc.
1.77%136.441.7%$143.34m
WATWaters Corporation
1.17%213.774.0%$124.80m
PENPenumbra, Inc.
2.27%145.958.7%$110.33m
ABMDABIOMED, Inc.
4.50%169.643.3%$105.68m

Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.